{"studyId":"brca_dldccc_2022","cancerTypeId":"brca","name":"Triple Negative Breast Cancer (DLDCCC, Cancer Discov 2022)","description":"Whole exome sequencing of 59 pre-treatment and 16 post-treatment triple-negative breast cancer samples and their matched normals as part of micro-scaled proteogenomic analysis to identify markers of chemotherapy resistance and response.","publicStudy":true,"pmid":"36001024","citation":"Anurag, Meenakshi et al. Cancer discovery 2022","groups":"","status":1,"importDate":"2026-01-05 17:21:55","allSampleCount":75,"sequencedSampleCount":75,"cnaSampleCount":75,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":75,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":0,"structuralVariantCount":0,"cancerType":{"id":"brca","name":"Invasive Breast Carcinoma","dedicatedColor":"HotPink","shortName":"BRCA","parent":"breast"},"readPermission":true,"resourceCounts":[]}